1. Home
  2. ELTX vs LITB Comparison

ELTX vs LITB Comparison

Compare ELTX & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$2.18

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

LITB

LightInTheBox Holding Co. Ltd.

HOLD

Current Price

$3.10

Market Cap

57.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
LITB
Founded
2011
2007
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
57.1M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
ELTX
LITB
Price
$2.18
$3.10
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
266.2K
5.0K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
N/A
EPS
N/A
N/A
Revenue
$2,301,000.00
N/A
Revenue This Year
N/A
$14.50
Revenue Next Year
N/A
$11.59
P/E Ratio
N/A
$10.96
Revenue Growth
N/A
N/A
52 Week Low
$2.34
$1.63
52 Week High
$16.00
$4.17

Technical Indicators

Market Signals
Indicator
ELTX
LITB
Relative Strength Index (RSI) 24.01 50.28
Support Level N/A $2.82
Resistance Level $3.32 $3.34
Average True Range (ATR) 0.13 0.16
MACD -0.03 0.01
Stochastic Oscillator 1.09 54.17

Price Performance

Historical Comparison
ELTX
LITB

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is a e-commerce company, providing a diverse range of affordable lifestyle products directly to consumers. Its brands include Ador, a women's fashion brand targeting women aged 35-55; the second is a golf apparel brand focusing on female golfers aged 35 and above; the third is a women's light party dress brand for the age group of 30 and above. It offers customers products through websites and mobile applications. The company operates and reviews its performance in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of the provision of logistic services to companies and individual customers.

Share on Social Networks: